April 14, 2009

IN RE: Bayer Corp. Combination Aspirin Products Marketing and Sales Practices Litigation

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


  1. May 17, 2012

    Bayer Pays $15M To Soothe Consumers In Aspirin MDL

    Bayer Corp. has agreed to pay $15 million to resolve class action claims that it misled consumers into believing its combination aspirin drugs had received regulatory approval, according to a settlement motion filed in New York federal court Wednesday.

2 other articles on this case. View all »


To view the parties, register now.